Skip to main content
Log in

Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients

  • Special Contributions
  • Published:
Journal of in Vitro Fertilization and Embryo Transfer Aims and scope Submit manuscript

Abstract

There is a distinct pattern of response to gonadotropin stimulation in some patients marked by high peak estradiol (E2) levels, multifollicular ovarians response, and elevated basal luteinizing hormone (LH)/follicle-stimulating hormone (FSH) ratios. We reviewed the stimulation profiles of five such high-responder patients who failed to conceive during in vitro fertilization with ovarian stimulation using pure FSH. All patients had baseline LH/FSH >1.5 and peak E2>800 pg/ml. One cycle was canceled prior to hCG administration because of marked ovarian response (E2>2500 pg/ml, multiple small follicles). In a subsequent cycle, all patients were pretreated with the gonadotropin releasing-hormone agonist (GnRHa) leuprolide acetete for 10–14 days prior to initiation of FSH for ovarian stimulation. Leuprolide was continued until the day of hCG administration. During cycles using GnRHa, there was a statistically significant decrease (P <0.05) in serum FSH on day 3 (<5 vs 8.3 mIU/ml), serum E2 on day 3 (14.6 vs 34.6 pg/ml), and peak serum E2 (1197.6 vs 1923.0 pg/ml). Patients during cycles with GnRHa had a greater number of preovulatory (8.6 vs 3.0) and total (12.4 vs 6.0) oocytes retrieved (P<0.05). The fertilization rate of preovulatory oocytes was also higher during cycles using GnRHa (83 vs 64%). Two pregnancies occurred in the cycles pretreated with GnRHa. These preliminary data indicate that in high-responder patients, a combination of GnRHa and pure FSH results in lower E2 levels during the stimulation cycle and a greater number of total and mature oocytes retrieved and fertilized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shaw RE, Ndukwe G, Imoedemhe D, Burford G, Chan R: Stimulation of multiple follicular growth for in vitro fertilization by administration of pulsatile luteinizing hormonereleasing hormone during the midfollicular phase. Fertil Steril 1986;46:135–137

    Google Scholar 

  2. Jones HW Jr, Jones GS, Andrews MC, Acosta AA, Bundren C, Garcia J, Sandow B, Veeck L, Wilkes C, Witmyer J, Wortham JE, Wright G: The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14–21

    Google Scholar 

  3. Jones GS, Acosta AA, Garcia JE, Bernardus RE, Rosenwaks Z: The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women. Fertil Steril 1985;43:696–702

    Google Scholar 

  4. Quigley MM, Schmidt CL, Beauchamp PS, Pace-Owens S, Berkowitz AS, Wolf DP: Enhanced follicular recruitment in an in vitro fertilization program: Clomiphene alone versus a clomiphene-human menopausal gonadotropin combination. Fertil Steril 1984;42:25–33

    Google Scholar 

  5. Muasher SJ: Stimulation protocols for patients with “atypical response.” Ann NY Acad Sci 1988;541:82–95

    Google Scholar 

  6. Kenigsberg D, Littman BA, Williams RF, Hodgen GD: Medical hypophysectomy. II. Variability of ovarian response to gonadotropin therapy. Fertil Steril 1984;42:116–126

    Google Scholar 

  7. Hodgen GD, Kenigsberg D, Collins FL, Schenken RS: Selection of the dominant ovarian follicle and hormonal enhancement of the natural cycle. Ann NY Acad Sci 1985;442:23–37

    Google Scholar 

  8. Veeck LL, Wortham JWE, Witmyer J, Sandow BA, Acosta AA, Garcia JE, Jones GS, Jones HW jr: Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization. Fertil Steril 1983;39:594–602

    Google Scholar 

  9. Muasher SJ, Garcia JE, Rosenwaks Z: The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization. Fertil Steril 1985;44:62–69

    Google Scholar 

  10. Romeau A, Acosta A, Jones GS, Liu HC, Jones D: Is the multifollicular ovarian response to stimulation desirable in an IVF program? Rev Iberoam Fertil Reprod Hum 1989; 6:520–525

    Google Scholar 

  11. Russell JB, Polan ML, DeCherney AH: The use of pure follicle-stimulation hormone for ovulation induction in normal ovulatory women in an in vitro fertilization program. Fertil Steril 1986;45:829–833

    Google Scholar 

  12. Erickson GF: An analysis of follicle development and ovum maturation. Sem Reprod Endocrinol 1986;4:233–254

    Google Scholar 

  13. Erickson GF, Hsueh AJW, Quigley ME, Rebar RW, Yen SS: Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab 1979;49:514–519

    Google Scholar 

  14. Raj SG, Berger MJ, Grimes EM, Taymor ML: The use of gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril 1977;28:1280–1284

    Google Scholar 

  15. Seibel MM, McArdle C, Smith D, Taymor ML: Ovulation induction in polycystic ovary syndrome with urinary folliclestimulating hormone or human menopausal gonadotropin. Fertil Steril 1985;43:703–708

    Google Scholar 

  16. Venuroli S, Paradisi R, Fabbri R, Magrini O, Porcu E, Flamigni C: Comparison between human urinary follicle stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary. Obstet Gynecol 1984;63:6–11

    Google Scholar 

  17. Charbonnel B, Krempf M, Blanchard P, Dano F, Delage C: Induction of ovulation in polycystic ovary syndrome with a combination of luteinizing hormone-releasing analog and exogenous gonadotropins. Fertil Steril 1987;47:920–924

    Google Scholar 

  18. Fleming R, Haxton MJ, Hamilton MPR, McCune GS, Black WP, Macnaughton MC, Coutis JRT: Succesful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins. Br J Obstet Gynaecol 1985;92:369–373

    Google Scholar 

  19. de Ziegler D, Cedars MI, Randle D, Lu JKH, Judd HL, Meldrum DR: Suppression of the ovary using a gonadotropin-releasing hormone agonist prior to stimulation for oocyte retrieval. Fertil Steril 1987;48:807–810

    Google Scholar 

  20. Awadalla SG, Friedman CI, Chin NW, Dodds W, Park JM, Kim MH: Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins. Fertil Steril 1987;48:811–815

    Google Scholar 

  21. Meldrum DR, Tsao Z, Monroe GD, Braustein J, Sladek J, Lu JKH, Vale W, Rivier J, Judd HL, Chang RJ: Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab 1984;58:755–757

    Google Scholar 

  22. Dahl KD, Pavlou SN, Kovacs WJ, Hsueh AJW: The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist. J Clin Endocrinol Metab 1986;63:792–794

    Google Scholar 

  23. Neveu S, Hedon B, Bringer J, Chinchole JM, Arnal F, Humeau C, Cristol P, Viala JL: Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639–643

    Google Scholar 

  24. Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, Rosenwaks Z: Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292–297

    Google Scholar 

  25. Forman R, Fries N, Testart J, Belaisch-Allart J, Hazout A, Frydman R: Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil Steril 1988;49:118–122

    Google Scholar 

  26. Lejeune B, Degueldre M, Camus M, Vekemans M, Opsomer L, Leroy F: In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Fertil Steril 1986;45:377–383

    Google Scholar 

  27. Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385–393

    Google Scholar 

  28. Moor RM, Trounson AO: Hormonal and follicular factors affecting maturation of sheep oocytes in vitro and their subsequent developmental capacity. J Reprod Fert 1977;49:101–109

    Google Scholar 

  29. Salat-Baroux J, Alvarez S, Antoine JM, Cornet D, Tibi C, Plachot M, Mandelbaum J: Results of IVF in the treatment of polycystic ovary disease. Hum Reprod 1988;3:331–335

    Google Scholar 

  30. Muasher SJ, Oehninger S, Simonetti S, Mata J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298–307

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edelstein, M.C., Brzyski, R.G., Jones, G.S. et al. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients. J Assist Reprod Genet 7, 172–176 (1990). https://doi.org/10.1007/BF01135684

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01135684

Key Words

Navigation